Table 2.

Demographic data of included patients, stratified according to the abbreviated REIN score

Abbreviated REIN score		≤4 n = 1523	5–6 n = 619	7–8 n = 338	≥9 n = 199	p-value
Screa at start (mg/dl)		7.2 ± 3.1	6.3 ± 2.7	6.4 ± 4.5	5.9 ± 3.1	<0.001
Weight (kg)		71.6 ± 15.7	71.6 ± 14.5	69.8 ± 14.5	69.3 ± 16.1	0.18
Height (cm)		166.5 ± 9.3	166.0 ± 8.1	168.5 ± 9.3	166.6 ± 9.1	0.21
Age at start (years)		64.0 ± 15.2	71.7 ± 11.0	77.5 ± 10.8	67.8 ± 14.3	<0.001
Female (%)		48.1	38.6	34.6	32.7	<0.001
Heart Failure	Stage 0–1	70.7	34.4	16.9	8.5	<0.001
	Stage 2	13.3	16.2	19.5	9.5
	Stage 3	13.4	23.7	34.0	62.3
	Stage 4	2.1	19.7	12.7	17.6
Angina Pectoris	None	86.6	66.2	61.2	54.3	<0.001
	Grade 1	7.4	14.1	16.0	16.1
	Grade 2	4.1	9.9	9.5	8.0
	Grade 3	1.4	6.9	10.1	14.6
Peripheral Vascular Disease						<0.001
None		87.2	71.9	70.4	61.3
Claudicatio		8.1	15.2	15.7	17.6
Resting ischemia		1.4	3.6	3.8	7.0
Necrosis/amputation		3.2	9.4	10.1	14.1
COPD	None	83.2	71.1	66.0	59.8	<0.001
	Mild	9.8	17.4	19.5	18.1
	Moderate	5.6	8.6	9.8	14.1
	Severe	1.4	2.9	4.7	8.0
Myocardial Infarction		11	25.5	27.8	33.2	<0.001
Percutaneous Coronary Intervention		13	22.6	25.7	25.6	<0.001
Arrhythmia		6.4	18.4	28.7	44.2	<0.001
Diabetes		30.2	39.7	37.3	34.7	<0.001
Diabetic nephropathy		23	26.8	24.0	23.6	0.3
CerebroVascular Disease		8.7	8.7	13.7	15.0	<0.001
Dementia		0.7	2.4	7.4	8.5	<0.001
Liver disease		4.7	4.2	4.0	6.5	<0.001
Left ventricular Hypertrophy		49.5	51.5	51.2	54.8	0.6
Cancer		8.5	19.1	29.9	34.7	0.2
Nutritional status	Normal	92	75.4	60.9	49.2	<0.001
	Malnutrition	7.4	20.2	31.7	37.7
	Severe malnutrition	0.6	4.4	13.1	13.1
Albumin (g/l)	<25	0	18.3	27.2	45.2	<0.001
	25–30	5.6	18.3	27.5	31.2
	30–35	19.2	33.4	30.5	22.1
	35–40	49.6	22.0	9.8	1.0
	>40	25.6	8.1	5.0	0.5
C-reactive protein (mg/L)	<15	73.3	54.1	44.1	40.7	<0.001
	15–60	20.1	29.4	35.2	33.7
	>60	6.6	16.5	20.7	25.6
Renal Replacement Therapy						<0.001
	Hospital HD	77.7	80.9	85.8	88.4
	Satellite HD	9.5	12.1	6.5	6.5
	PD	12.8	6.9	7.7	4.5